Shelton Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $501K | Hold |
|
|||||
|
2025
Q2 | $449K | Sell |
|
|||||
|
2025
Q1 | $402K | Sell |
|
|||||
|
2024
Q4 | $520K | Sell |
|
|||||
|
2024
Q3 | $458K | Sell |
|
|||||
|
2024
Q2 | $558K | Sell |
|
|||||
|
2024
Q1 | $572K | Sell |
|
|||||
|
2023
Q4 | $563K | Sell |
|
|||||
|
2023
Q3 | $508K | Sell |
|
|||||
|
2023
Q2 | $449K | Sell |
|
|||||
|
2023
Q1 | $496K | Hold |
|
|||||
|
2022
Q4 | $585K | Sell |
|
|||||
|
2022
Q3 | $533K | Hold |
|
|||||
|
2022
Q2 | $489K | Hold |
|
|||||
|
2022
Q1 | $470K | Hold |
|
|||||
|
2021
Q4 | $427K | Sell |
|
|||||
|
2021
Q3 | $499K | Hold |
|
|||||
|
2021
Q2 | $507K | Buy |
|